InstaRelease Delivery Technology InstaMeds oral dissolving strips leverage our InstaRelease delivery technology through the buccal membranes for mouth to body delivery without the need for injection.
It is not a routine prenatal supplementation method but rather a therapeutic intervention for specific needs
April 22, 2026: Removed from Category 2 On April 15, 2026, the FDA published a 503A category revision removing 12 peptides from Category 2 effective seven calendar days later (April 22)
In rodent studies, semaglutide was associated with an increased incidence of thyroid C-cell tumours, including medullary thyroid carcinoma (MTC)
Orders before 2PM EST ship same day
Here are answers to the most frequently asked questions from those exploring BPC-157 for conditions like IBS, leaky gut, and ulcers